Insights+: COVID-19 Healthcare News Monthly Updates – August 2020

 Insights+: COVID-19 Healthcare News Monthly Updates – August 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease. PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date.

83. GSK and VIR Biotechnology Initiate P-II/III COMET-ICE Study of VIR-7831 Against COVID-19

Aug 31, 2020 | Clinical Trial

82. AstraZeneca Expands the Development of AZD1222 into P-III Study in the US Across All Adult Age Groups

Aug 31, 2020 | Clinical Trial

81. Johnson & Johnson Collaborates with the Government of Canada to Supply its Ad26.COV2.S for COVID-19

Aug 31, 2020 | Clinical Trial

80. BeiGene Signs an Exclusive License Agreement with Singlomics for Neutralizing COVID-19 Antibodies

Aug 27, 2020 | Collaboration

79. Abbott’s BinaxNOW COVID-19 Ag Card Receives the US FDA’s EUA to Detect SARS-CoV-2 Infection

Aug 27, 2020 | Diagnostics

78. Laurent Pharmaceuticals Receives Approval from FDA to Initiate its COVID-19 Phase 2 Clinical Trial in the United States

Aug 27, 2020 | Regulatory

77. FDC Launches Two Variants of Favipiravir for COVID-19 in India

Aug 27, 2020 | Launch

76. Q BioMed Initiates GMP Production of Novel COVID-19 Therapeutic for Clinical Trial Program

Aug 26, 2020 | Clinical Trial

75. INTAS Develops COVID-19 Hyperimmune Globulin

Aug 26, 2020 | Regulatory

74. Capricor Therapeutics Report the US FDA Acceptance of its IND Application for a Phase 2 Clinical Trial of CAP-1002 in Patients with COVID-19

Aug 25, 2020 | Regulatory

73. AstraZeneca Initiates P-I Study of AZD7442 Against COVID-19

Aug 25, 2020 | Clinical Trial

72. Bolder BioTechnology Announces Positive Preclinical Data for Use of BBT-032 to Inhibit Growth of the SARS-CoV-2 Virus

Aug 25, 2020 | Clinical Trial

71. Asalyxa Bio Launches with Novel Neutrophil-Targeting Drug Delivery Platform Technology and Lead Candidate, ASX-100 for ARDS and COVID-19 Patients

Aug 25, 2020 | Launch

70. Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19

Aug 25, 2020 | DigiHealth

69. EpiVax Announces Licensing of COVID-19 Vaccine Candidate to EpiVax Therapeutics

Aug 25, 2020 | Collaboration

68. Mereo BioPharma Initiates P-Ib/II Clinical Trial with Alvelestat in COVID-19 Respiratory Disease

Aug 25, 2020 | Clinical Trial

67. Altimmune and the University of Alabama at Birmingham Report Potent Respiratory Mucosal T Cell Responses in Preclinical Study of Single-Dose Intranasal COVID-19 Vaccine Candidate, AdCOVID

Aug 25, 2020 | Clinical Trial

66. Partner Therapeutics Initiates Patient Enrollment in US Clinical Trial Evaluating Leukine (rhuGM-CSF, sargramostim) in COVID-19 Patients

Aug 25, 2020 | Clinical Trial

65. First Rapid Corona Antigen Test Approved for Clinical Study in Germany

Aug 25, 2020 | Diagnostics

64. Flexibility, Speed Enabling Actifio to Help in Pursuit of COVID-19 Treatments

Aug 25, 2020 | DigiHealth

63. Kedrion Biopharma and Kamada Continue Their Collaboration to Develop a New Anti-COVID Plasma-Based Treatment

Aug 25, 2020 | Collaboration

62. UNION therapeutics Completes Dosing of Healthy Volunteers with UNI911 (inhaled niclosamide) for COVID-19

Aug 25, 2020 | Clinical Trial

61. Medicure AGGRASTAT Shows Promise in Treating Thrombotic Complications Due to COVID-19 in Early Clinical Reports

Aug 25, 2020 | Clinical Trial

60. Terumo and Cytosorbent Collaborate to Commercialize CytoSorb in Ten US COVID-19 Hotspot States

Aug 25, 2020 | Collaboration

59. Pfizer and BioNTech Plan for Regulatory Review of its COVID-19 Vaccine in October 2020

Aug 21, 2020 | Regulatory

58. BioSymetrics Signs an Agreement with Janssen and Sema4 to Utilize AI for the Prediction of COVID-19

Aug 20, 2020 | Collaboration

57. Sorrento Files IND for STI-1499 (COVI-GUARD) in Patients Hospitalized with COVID-19

Aug 20, 2020 | Regulatory

56. Qiagen Launches QIAseq SARS-CoV-2 Primer Panel for Tracking COVID-19 Mutations and Strains

Aug 20, 2020 | Launch

55. Fitbit Reports Results of its COVID-19 Study for Early Detection of Diseases

Aug 20, 2020 | DigiHealth

54. Finding Clues to a Successful Immune Response in the T Cells of Recovered COVID-19 Patients

Aug 21, 2020 | Clinical Trial

53. JanOne to Discuss JAN101 for Treatment of PAD and Potential Applications for COVID-19 Vascular Complications

Aug 21, 2020 | Clinical Trial

52. Co-Diagnostics Receives Enhanced U.S. Patent Protection for CoPrimer Technology Used in COVID-19 Test

Aug 20, 2020 | Diagnostics

51. Clinical Research Trials Underway to Study COVID-19 Impact on Dialysis Patients

Aug 20, 2020 | Clinical Trial

50. LumiraDx Receives FDA Emergency Use Authorization for Point of Care COVID-19 Antigen Test

Aug 20, 2020 | Diagnostics

49. Zymo Research Granted CE IVD Mark for Quick SARS-CoV-2 rRT-PCR Kit

Aug 20, 2020 | Diagnostics

48. Regeneron Collaborates with Roche to Improve the Global Supply of REGN-COV2 Against COVID-19

Aug 19, 2020 | Collaboration

47. Hackensack Meridian Health Observational Study Identifies Drug that Improves Survival in Sickest COVID-19 Patients

Aug 19, 2020 | Clinical Trial

46. Bio-Techne and Leica Biosystems Accelerates Disease Research with RNAscope COVID-19 Probes and the BOND RX

Aug 19, 2020 | Clinical Trial

45. Ampio Provides Update on COVID-19 Clinical Trial Activities

Aug 19, 2020 | Clinical Trial

44. Harbour BioMed, Utrecht University, Erasmus Medical Center, Viroclinics-DDL and Kiadis Pharma Collaborate to Develop Monoclonal Antibody for COVID-19

Aug 19, 2020 | Collaboration

43. NIH Delivers $4.3 Million to Support Convalescent Plasma Clinical Trial

Aug 18, 2020 | Grant

42. AstraZeneca Collaborates with mAbxience to Produce COVID-19 Vaccine in Latin America

Aug 18, 2020 | Collaboration

41. Vanda’s Interim Analysis from ODYSSEY Study Shows Tradipitant may Accelerate Clinical Improvement in Patients with COVID-19 Pneumonia

Aug 18, 2020 | Clinical Trial

40. BOLD-100 Significantly Outperforms Remdesivir Head-to-Head in SARS-CoV-2 (COVID-19) Model

Aug 17, 2020 | Clinical Trial

39. Pharming Announces the Publication of Data from a Compassionate Use Programme of RUCONEST in COVID-19 patients in a Peer-Reviewed Journal

Aug 17, 2020 | Clinical Trial

38. Novavax Collaborates with UK Government to Supply 60M Doses of NVX-CoV2373 to Combat COVID-19

Aug 14, 2020 | Collaboration

37. SK bioscience Collaborate with Novavax to Supply Antigen for COVID-19 Vaccine

Aug 14, 2020 | Collaboration

36. EC Concludes Exploratory Talks with J&J to Supply 200M Doses of COVID-19 Vaccine

Aug 14, 2020 | Collaboration

35. AstraZeneca to Initiate Production of its COVID-19 Vaccine Early in 2021

Aug 14, 2020 | Clinical Trial

34. Algernon Announces Enrollment of First U.S. Patient in Multinational Phase 2b/3 Human Study of Ifenprodil for Treatment of COVID-19

Aug 13, 2020 | Clinical Trial

33. UNION Therapeutics Enters Option Agreement to Acquire Worldwide Exclusive License for COVID-19 Technologies Developed by TFF Pharmaceuticals

Aug 13, 2020 | Collaboration

32. Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds

Aug 13, 2020 | Collaboration

31. Alphabet’s Verily Establishes CLIA-Certified Lab Focusing on COVID-19 Testing

Aug 13, 2020 | Diagnostics

30. Zydus Launches Cheapest Version of Remdesivir at $37.41 per Vial in India

Aug 13, 2020 | Launch

29. Puradigm Announces Successful Tests of its Proactive Air and Surface Purification Technology in Deactivating SARS-CoV-2

Aug 10, 2020 | Diagnostics

28. New Study Proves Asclepius Meditec’s Hydrogen Oxygen Generator Helps Improve COVID-19 Disease Severity and Dyspnea

Aug 10, 2020 | Diagnostics

27. Vela Diagnostics’ ViroKey SARS-CoV-2 RT-PCR Test Receives the US FDA’s Emergency Use Authorization

Aug 07, 2020 | Diagnostics

26. Daiichi Sankyo Selected as Provider for Japanese Government’s “Emergent Initiative to Build Production Capacity for COVID-19 Vaccines’’

Aug 07, 2020 | Collaboration

25. Serum Institute to Produce COVID-19 Vaccines From AstraZeneca, Novavax

Aug 07, 2020 | Collaboration

24. Amarin Supports Study of Vascepa in Reducing Viral Upper Respiratory Infection

Aug 07, 2020 | Clinical Trial

23. Covistat, Biopharmaceutical Company Developing Low-Cost COVID-19 Treatment Acquires IP From World Leader in Respiratory Disease Medicine

Aug 06, 2020 | Collaboration

22. Moderna Prices its COVID-19 Vaccine at $32-$37 per Dose for Smaller Volume Agreements

Aug 06, 2020 | Collaboration

21. Johnson & Johnson Signs an Agreement with the US Government to Supply 100M Doses of COVID-19 Vaccine Worth ~$1B

Aug 06, 2020 | Collaboration

20. Glenmark Introduces FabiFlu (400mg) to Reduce Pill Burden of COVID-19 Treatment

Aug 06, 2020 | Launch

19. NIH Begins Clinical Trial Testing of Remdesivir + Interferon Beta-1a for COVID-19

Aug 06, 2020 | Clinical Trial

18. SAB Biotherapeutics Awarded $35.6M from U.S. Department of Defense for COVID-19 and Scaling Rapid Response Antibody Program

Aug 06, 2020 | Grant

17. Pfizer AND BioNTech To Supply BNT162 mRNA- based Vaccine Candidate in Canada

Aug 05, 2020 | Collaboration

16. Revive Therapeutics Update Following U.S. FDA Approval of Phase 3 Clinical Trial for Bucillamine in COVID-19

Aug 05, 2020 | Regulatory

15. Texas Startup Industrial Genetics Launches Surface and Wastewater Testing for the COVID-19 Virus (SARS-CoV-2)

Aug 05, 2020 | Launch

14. Zydus Cadila Announces Completion of Dosing in Phase I Clinical Trial of ZyCoV-D

Aug 05, 2020 | Clinical Trial

13. Centex Studies-Lake Charles to be the Only Site in SWLA to Run AstraZeneca COVID Vaccine Clinical Trial

Aug 05, 2020 | Clinical Trial

12. Celularity Announces the Activation of first California Clinical Trial Site following CIRM Grant Award to Advance Treatments for COVID-19

Aug 05, 2020 | Grant

11. Lupin and SunPharma Launch Generic Favipiravir to Treat Mild to Moderate COVID-19 in India

Aug 05, 2020 | Launch

10. BioNTech and Fosun Pharma Initiate Clinical Trial of BNT162b1 Against COVID-19 in China

Aug 05, 2020 | Clinical Trial

9. Eli Lilly in Collaboration with NIAID Initiate P-III Study of LY-CoV555 to Prevent COVID-19

Aug 04, 2020 | Collaboration

8. Sanofi and GSK Receive $2.1B from the US Government to Supply 100M Doses of COVID-19 Vaccine

Aug 04, 2020 | Grant

7. Tiziana Life Sciences Expedite Clinical Development Plan for TZLS-501 for COVID-19

Aug 04, 2020 | Clinical Trial

6. Novavax Reports Positive Early Results for Experimental COVID-19 Vaccine NVX-CoV2373

Aug 04, 2020 | Clinical Trial

5. VERU-111 Suppresses Key Cytokines Responsible for Severe Acute Respiratory Distress Syndrome in COVID-19

Aug 04, 2020 | Clinical Trial

4. Angion Enrolls First Patients in Phase 2 Clinical Trial of ANG-3777 in Patients with Acute Lung Injury Associated with COVID-19 Pneumonia

Aug 04, 2020 | Clinical Trial

3. Innovation Pharmaceuticals and US Regional Biocontainment Laboratory Nearing Completion of Brilacidin Anti-SARS-CoV-2 (COVID-19) In Vitro Testing

Aug 04, 2020 | Diagnostic

2. Neutrolis Announces Development Of First-In-Class Treatment Targeting Neutrophil Extracellular Traps (NETs) For Patients With Severe COVID-19

Aug 03, 2020 | Clinical Trial

1. Rival Drugmakers Launch Joint Trial of Medicines for COVID-19

Aug 03, 2020 | Clinical Trial

Related Post : Insights+: COVID-19 Healthcare News Monthly Updates – July 2020

Tuba Khan

Tuba Khan is an Editor and Digital Marketing expert at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in Lifesciences industry. She covers Pharma, Medical devices, Diagnostics and Digital health segment. Tuba also has an experience of digital and social media marketing and can run the campaign independently. She is also certified as a Digital marketer and social media marketer. She can be contacted on tuba@pharmashots.com

Related post